Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × larotrectinib × Clear all

NCT04879121 2026-04-16

Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors

Phase 2 Recruiting

Neoplasm Metastasis